Pathogen activators of plasminogen

Journal of Thrombosis and Haemostasis

Volumn 13, Issue S1, 2015, Pages S106-S114

  Verhamme, I M ^a   Panizzi, P R ^b   Bock, P E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Enzymology; Fibrinolysis; Plasminogen; Streptococcus; Streptokinase

Indexed keywords

FIBRIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; BACTERIAL PROTEIN; CARRIER PROTEIN; PLASMIN; PLASMINOGEN-BINDING PROTEIN, BACTERIA; PROTEIN BINDING; VIRULENCE FACTOR;

AMINO TERMINAL SEQUENCE; BACTERIAL VIRULENCE; BINDING AFFINITY; CATALYSIS; CONFORMATIONAL TRANSITION; COUPLING FACTOR; ENZYME SUBSTRATE; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; ANIMAL; BLOOD; ENZYMOLOGY; FIBRINOLYSIS; METABOLISM; MICROBIOLOGY; MOLECULAR MODEL; PATHOGENICITY; STREPTOCOCCUS PYOGENES; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; CARRIER PROTEINS; FIBRIN; FIBRINOLYSIN; FIBRINOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, MOLECULAR; PLASMINOGEN; PROTEIN BINDING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOKINASE; VIRULENCE; VIRULENCE FACTORS;

EID: 84931376001     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12939     Document Type: Review

References (60)

1. Ralph AP, Carapetis JR. Group a streptococcal diseases and their global burden. Curr Top Microbiol Immunol 2013; 368: 1-27.
2. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003; 3: 191-200.
3. Cook SM, Skora A, Gillen CM, Walker MJ, McArthur JD. Streptokinase variants from Streptococcus pyogenes isolates display altered plasminogen activation characteristics - implications for pathogenesis. Mol Microbiol 2012; 86: 1052-62.
4. Cook SM, Skora A, Walker MJ, Sanderson-Smith ML, McArthur JD. Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variants. Biochem J 2014; 458: 23-31.
5. McArthur JD, Cook SM, Venturini C, Walker MJ. The role of streptokinase as a virulence determinant of Streptococcus pyogenes-potential for therapeutic targeting. Curr Drug Targets 2012; 13: 297-307.
6. Kalia A, Bessen DE. Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol 2004; 186: 110-21.
7. Zhang Y, Liang Z, Hsueh H-T, Ploplis VA, Castellino FJ. Characterization of streptokinases from group A Streptococci reveals a strong functional relationship that supports the coinheritance of plasminogen-binding M protein and cluster 2b streptokinase. J Biol Chem 2012; 287: 42093-103.
8. Sikri N, Bardia A. A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 2007; 34: 318-27.
9. Law Ruby HP, Caradoc-Davies T, Cowieson N, Horvath Anita J, Quek Adam J, Encarnacao Joanna A, Steer D, Cowan A, Zhang Q, Lu Bernadine GC, Pike Robert N, Smith AI, Coughlin Paul B, Whisstock James C. The X-ray crystal structure of full-length human plasminogen. Cell Rep 2012; 1: 185-90.
10. Xue Y, Bodin C, Olsson K. Crystal structure of the native plasminogen reveals an activation-resistant compact conformation. J Thromb Haemost 2012; 10: 1385-96.
11. Boxrud PD, Bock PE. Streptokinase binds preferentially to the extended conformation of plasminogen through lysine binding site and catalytic domain interactions. Biochemistry 2000; 39: 13974-81.
12. Verhamme IM, Bock PE. Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism. J Biol Chem 2014; 289: 28006-18.
13. Walker MJ, McArthur JD, McKay F, Ranson M. Is plasminogen deployed as a Streptococcus pyogenes virulence factor? Trends Microbiol 2005; 13: 308-13.
14. Stillfried GE, Saunders DN, Ranson M. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity. Breast Cancer Res 2007; 9: R14.
15. Parry MA, Zhang XC, Bode I. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Trends Biochem Sci 2000; 25: 53-9.
16. Huber R, Bode W. Structural basis of activation and action of trypsin. Acc Chem Res 1978; 11: 114-22.
17. Bode W, Huber R. Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin. FEBS Lett 1976; 68: 231-6.
18. Boxrud PD, Verhamme IM, Fay WP, Bock PE. Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation. J Biol Chem 2001; 276: 26084-9.
19. Wang S, Reed GL, Hedstrom L. Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis. Biochemistry 1999; 38: 5232-40.
20. Renatus M, Engh RA, Stubbs MT, Huber R, Fischer S, Kohnert U, Bode W. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J 1997; 16: 4797-805.
21. Friedrich R, Panizzi P, Fuentes-Prior P, Richter K, Verhamme I, Anderson PJ, Kawabata S, Huber R, Bode W, Bock PE. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 2003; 425: 535-9.
22. Panizzi P, Friedrich R, Fuentes-Prior P, Bode W, Bock PE. The staphylocoagulase family of zymogen activator and adhesion proteins. Cell Mol Life Sci 2004; 61: 2793-8.
23. Boxrud PD, Bock PE. Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase. J Biol Chem 2004; 279: 36642-9.
24. Boxrud PD, Verhamme IM, Bock PE. Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase. J Biol Chem 2004; 279: 36633-41.
25. Kosow DP. Kinetic mechanism of the activation of human plasminogen by streptokinase. Biochemistry 1975; 14: 4459-65.
26. Verhamme IM, Bock PE. Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation. J Biol Chem 2008; 283: 26137-47.
27. Tharp AC, Laha M, Panizzi P, Thompson MW, Fuentes-Prior P, Bock PE. Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate. J Biol Chem 2009; 284: 19511-21.
28. Nolan M, Bouldin SD, Bock PE. Full time course kinetics of the streptokinase-plasminogen activation pathway. J Biol Chem 2013; 288: 29482-93.
29. Wang X, Lin X, Loy JA, Tang J, Zhang XC. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 1998; 281: 1662-5.
30. Boxrud PD, Fay WP, Bock PE. Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen. J Biol Chem 2000; 275: 14579-89.
31. Panizzi P, Boxrud PD, Verhamme IM, Bock PE. Binding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase plasmin(ogen) catalytic complexes. J Biol Chem 2006; 281: 26774-8.
32. Lin LF, Houng A, Reed GL. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms. Biochemistry 2000; 39: 4740-5.
33. Loy JA, Lin X, Schenone M, Castellino FJ, Zhang XC, Tang J. Domain interactions between streptokinase and human plasminogen. Biochemistry 2001; 40: 14686-95.
34. Liu L, Sazonova IY, Turner RB, Chowdhry SA, Tsai J, Houng AK, Reed GL. Leucine 42 in the fibronectin motif of streptokinase plays a critical role in fibrin-independent plasminogen activation. J Biol Chem 2000; 275: 37686-91.
35. Wang X, Tang J, Hunter B, Zhang XC. Crystal structure of streptokinase beta-domain. FEBS Lett 1999; 459: 85-9.
36. Dhar J, Pande AH, Sundram V, Nanda JS, Mande SC, Sahni G. Involvement of a nine-residue loop of streptokinase in the generation of macromolecular substrate specificity by the activator complex through interaction with substrate kringle domains. J Biol Chem 2002; 277: 13257-67.
37. Chaudhary A, Vasudha S, Rajagopal K, Komath SS, Garg N, Yadav M, Mande SC, Sahni G. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis. Protein Sci 1999; 8: 2791-805.
38. Rios-Steiner JL, Schenone M, Mochalkin I, Tulinsky A, Castellino FJ. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol 2001; 308: 705-19.
39. Cnudde SE, Prorok M, Castellino FJ, Geiger JH. X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM. Biochemistry 2006; 45: 11052-60.
40. Bergmann S, Wild D, Diekmann O, Frank R, Bracht D, Chhatwal GS, Hammerschmidt S. Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol 2003; 49: 411-23.
41. McArthur JD, McKay FC, Ramachandran V, Shyam P, Cork AJ, Sanderson-Smith ML, Cole JN, Ringdahl U, Sjöbring U, Ranson M, Walker MJ. Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation. FASEB J 2008; 22: 3146-53.
42. Wiles KG, Panizzi P, Kroh HK, Bock PE. Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation. J Biol Chem 2010; 285: 21153-64.
43. Bean RR, Verhamme IM, Bock PE. Role of the streptokinase alpha-domain in the interactions of streptokinase with plasminogen and plasmin. J Biol Chem 2005; 280: 7504-10.
44. Berge A, Sjöbring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem 1993; 268: 25417-24.
45. Macheboeuf P, Buffalo C, Fu CY, Zinkernagel AS, Cole JN, Johnson JE, Nizet V, Ghosh P. Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature 2011; 472: 64-8.
46. Khil J, Im M, Heath A, Ringdahl U, Mundada L, Cary Engleberg N, Fay WP. Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms. J Infect Dis 2003; 188: 497-505.
47. Sun H. Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies. J Thromb Haemost 2011; 9(Suppl 1): 189-94.
48. Fu Q, Figuera-Losada M, Ploplis VA, Cnudde S, Geiger JH, Prorok M, Castellino FJ. The lack of binding of VEK-30, an internal peptide from the group A streptococcal M-like protein, PAM, to murine plasminogen is due to two amino acid replacements in the plasminogen kringle-2 domain. J Biol Chem 2008; 283: 1580-7.
49. Marcum JA, Kline DL. Species specificity of streptokinase. Comp Biochem Physiol B 1983; 75: 389-94.
50. Yakovlev SA, Rublenko MV, Izdepsky VI, Makogonenko EM. Activating effect of the plasminogen activators on plasminogens of different mammalia species. Thromb Res 1995; 79: 423-8.
51. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305: 1283-6.
52. Li Z, Ploplis VA, French EL, Boyle MD. Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis 1999; 179: 907-14.
53. Gonias SL, Einarsson M, Pizzo SV. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin. J Clin Invest 1982; 70: 412-23.
54. Degen SJ, Bell SM, Schaefer LA, Elliott RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 1990; 8: 49-61.
55. Ringdahl U, Svensson M, Wistedt AC, Renne T, Kellner R, Muller-Esterl W, Sjöbring U. Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes. J Biol Chem 1998; 273: 6424-30.
56. Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, Rohde M, Itzek A, Sun H, Ginsburg D, Kotb M, Nizet V, Chhatwal GS, Walker MJ. Trigger for group A streptococcal M1T1 invasive disease. FASEB J 2006; 20: 1745-7.
57. Cederholm-Williams SA, De Cock F, Lijnen HR, Collen D. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin. Eur J Biochem 1979; 100: 125-32.
58. Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G, Purchio TF, Caparon MG, Lipsitch M, Contag PR. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 2001; 69: 3350-8.
59. Loh JM, Proft T. Toxin-antitoxin-stabilized reporter plasmids for biophotonic imaging of group A streptococcus. Appl Microbiol Biotechnol 2013; 97: 9737-45.
60. Sun H, Xu Y, Sitkiewicz I, Ma Y, Wang X, Yestrepsky BD, Huang Y, Lapadatescu MC, Larsen MJ, Larsen SD, Musser JM, Ginsburg D. Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci USA 2012; 109: 3469-74.